Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000432654

Medchemexpress LLC Naloxegol oxalate | 1354744-91-4 | 99.9% | C36H55NO15 | 50 MG
SDP

Catalog No. 5000432654
Encompass_Preferred

Naloxegol oxalate is an orally active, peripherally acting μ-opioid receptor antagonist. It works by inhibiting the binding of opioids to μ-opioid receptors in the gastrointestinal tract, thereby alleviating opioid-induced conditions like hypomotility, delayed transit, hypertonicity, and increased fluid reabsorption. This compound is primarily used in research related to opioid-induced constipation.

  • Orally active, peripherally acting μ-opioid receptor antagonist
  • Inhibits opioid binding in the gastrointestinal tract
  • Alleviates opioid-induced gastrointestinal hypomotility
  • Used in research for opioid-induced constipation
  • Binds with high affinity to μ-opioid and κ-opioid receptors
  • Shows low affinity to δ-opioid receptors with no significant activity at non-opioid targets

Catalog No. 50-004-32654 Supplier Medchemexpress LLC Supplier No. HYA0118A50MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Naloxegol oxalate is an orally active, peripherally acting μ-opioid receptor antagonist. It works by inhibiting the binding of opioids to μ-opioid receptors in the gastrointestinal tract, thereby alleviating opioid-induced conditions like hypomotility, delayed transit, hypertonicity, and increased fluid reabsorption. This compound is primarily used in research related to opioid-induced constipation.

  • Orally active, peripherally acting μ-opioid receptor antagonist
  • Inhibits opioid binding in the gastrointestinal tract
  • Alleviates opioid-induced gastrointestinal hypomotility
  • Used in research for opioid-induced constipation
  • Binds with high affinity to μ-opioid and κ-opioid receptors
  • Shows low affinity to δ-opioid receptors with no significant activity at non-opioid targets

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.